- Direction
- Inflecting
- Own history
- —
- Peers
- 50th
- Persistence
- REVERSING
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTEXELIXIS, INC.'s latest supported as-filed period reports revenue of $658.7M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.38% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 42.50% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 10.20% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 4.53% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 96.02% · CORE
Level · gp.fundamentals.operating_margin
Raw value 40.75% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents increased 71.2%; Operating cash flow increased 528.1%.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 10.6%; Operating margin moved 193 bp higher; Operating income increased 16.3%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents decreased 19.0%; Operating cash flow decreased 3.6%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 140.2%; Capex / revenue moved 58 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 10.2%; Operating margin moved 118 bp higher; Operating income increased 13.5%.
3 evidence-backed componentsCash & equivalents changed +71.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
EXEL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0000939767-26-000116SEC ↗8-KOct 29, 2026Period Oct 29, 20260000939767-26-000114SEC ↗8-KSep 11, 2026Period Sep 10, 20260000939767-26-000108SEC ↗8-KAug 31, 2026Period Aug 31, 20260000939767-26-000104SEC ↗4Aug 12, 2026Period Aug 10, 20260000939767-26-000101SEC ↗10-QAug 5, 2026Period Jul 3, 20260000939767-26-000098SEC ↗8-KAug 5, 2026Period Aug 5, 20260000939767-26-000096SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 10, 2026Filed Aug 12, 2026 | Beckerle Mary CDirector | Open Market SaleDirect | 9,812 | $54 | $526,512 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 31.80% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 4.36% · OPTIONAL
Free-cash-flow proxy changed +552.0% from the comparable as-filed period.
Operating cash flow changed +528.1% from the comparable as-filed period.
Total assets changed -11.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed -9.0% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Shares outstanding changed -8.0% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Current liabilities changed +10.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-10-02. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0000939767-26-000085